Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 695 results found. Search for [ Bharat BioTech ]

Results 1 to 21 of 695
BusinessToday.In
April 20, 2021
Hancock said one of the concerns about the Indian variant is that the vaccines may be less effective, in terms of transmission and/or in terms of reducing hospitalisation and death. 


BusinessToday.In
April 20, 2021
More than 44 lakh vaccine doses were squandered out of 10 crore doses used by states till April 11, as disclosed by an RTI reply


PTI
April 20, 2021
The company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application


Manoj Sharma
April 20, 2021
Companies like Serum Institute and Bharat Biotech need to disclose the price of the vaccines to be distributed to states and private players before May 1, the date when phase 3 of the vaccination starts. India's rising Covid tally has forced the government to double down on its action against coronavirus


BusinessToday.In
April 20, 2021
Under the Phase 3 vaccination policy, vaccine makers will supply 50 per cent of their doses to the Centre and the remaining 50 per cent to states and in the open market


Ashutosh Kumar
April 19, 2021
The government will make pre-payment to both Serum Institute of India and Bharat Biotech for the vaccine supply. \"This will serve as an incentive to the two vaccine suppliers,\" said a source


PTI
April 19, 2021
Terming the second wave as 'concerning and scaring', Chandrasekaran also called for accelerated tracing and vaccination and tracking supply of the vaccines while asserting that a nationwide lockdown is not the solutionas it would hit the economy hard


BusinessToday.In
April 19, 2021
Production of Covaxin to rise 10 times in September; Coronavirus vaccine supplies for small states are being replenished in a week, says Harsh Vardhan


PTI
April 18, 2021
India is battling a massive surge in COVID-19 cases and health ministry data updated on Sunday showed that a record single-day rise of 2,61,500 coronavirus infections has taken the country's total tally to 1,47,88,109


BusinessToday.In
April 16, 2021
The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.


Rashi Bisaria
New Delhi, April 16, 2021
Apple announces first-ever $200 million carbon removal initiative Cupertino giant Apple on Thursday, April 15, announced a first-of-its-kind carbon removal initiative called 'Restore Fund'. Under this new initiative investments will be made in forestry projects to remove carbon from the atmosphere. The new initiative is part of Apple's broader goal of becoming carbon neutral across its entire value chain by 2 COVID-19 vaccine: Centre permits Mumbai's Haffkine Institute to produce Covaxin...


BusinessToday.In
April 16, 2021
In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.


PB Jayakumar
April 14, 2021
The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India


BusinessToday.In
April 14, 2021
Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.


BusinessToday.In
April 13, 2021
The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


Joe C Mathew
April 11, 2021
India's two approved COVID-19 vaccine makers - Serum Institute of India and Bharat Biotech - are struggling to keep pace with the increasing demand for COVID-19 vaccines within India


BusinessToday.In
April 11, 2021
Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy's Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V


PAGES 1 OF 35  12345